| C9744 | Ultrasound, abdominal, with contrast |
| C9791 | Magnetic resonance imaging with inhaled hyperpolarized xenon-129 contrast agent, chest, including preparation and administration of agent |
| C8920 | Magnetic resonance angiography without contrast followed by with contrast, pelvis |
| C8933 | Magnetic resonance angiography without contrast followed by with contrast, spinal canal and contents |
| C8936 | Magnetic resonance angiography without contrast followed by with contrast, upper extremity |
| C8911 | Magnetic resonance angiography without contrast followed by with contrast, chest (excluding myocardium) |
| C8924 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, follow-up or limited study |
| G9455 | Patient underwent abdominal imaging with ultrasound, contrast enhanced ct or contrast mri for hcc |
| C8908 | Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral |
| C8905 | Magnetic resonance imaging without contrast followed by with contrast, breast; unilateral |
| A9698 | Non-radioactive contrast imaging material, not otherwise classified, per study |
| A9700 | Supply of injectable contrast material for use in echocardiography, per study |
| C8914 | Magnetic resonance angiography without contrast followed by with contrast, lower extremity |
| Q9953 | Injection, iron-based magnetic resonance contrast agent, per ml |
| Q9954 | Oral magnetic resonance contrast agent, per 100 ml |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
| C8925 | Transesophageal echocardiography (tee) with contrast, or without contrast followed by with contrast, real time with image documentation (2d) (with or without m-mode recording); including probe placement, image acquisition, interpretation and report |
